| Financial Year |
March 31 2023 |
| Monetary Funds |
844,995,271.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
431,392,606.44 |
| Advances to Suppliers |
459,836,465.72 |
| Other Receivables |
217,451,174.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,143,681,460.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
463,047,083.09 |
| Total Current Assets |
4,564,303,286.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
483,535,199.67 |
| Fixed Assetes |
6,276,837,650.38 |
| Under-construction Projects |
943,831,934.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,160,801,314.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
529,896,844.68 |
| Deferred Income Tax Assets |
104,120,819.24 |
| Other Non-Current Assets |
513,175,566.19 |
| Sub-Total of Non-Current Assets |
12,176,614,261.30 |
| Total Assets |
16,740,917,547.82 |
| Short-Term Loans |
3,777,524,713.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
421,354,351.31 |
| Accounts Payable |
973,401,717.96 |
| Accounts Received In Advance |
83,289,186.00 |
| Employee Compensation Payable |
122,272,102.70 |
| Taxes Payable |
79,254,507.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,639,806,159.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
377,053,366.47 |
| Other Current Liabilities |
79,967,227.90 |
| Sub-Total of Current Liabilities |
8,178,456,115.14 |
| Long-term Loans |
51,721,732.63 |
| Bonds Payable |
1,702,133,646.77 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
27,164,692.14 |
| Deferred Income Tax Liabilities |
25,836,438.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,293,030,568.72 |
| Total Liabilities |
12,471,486,683.86 |
| Paid-In Capital(Or Share Stock) |
849,733,508.00 |
| Capital Surplus |
1,709,049,800.05 |
| Surplus Reserve |
432,448,352.04 |
| LESS:Treasury Stock |
61,168,399.50 |
| Undistributed Profits |
1,071,804,051.75 |
| Minority Stockholder's Interest |
34,484,770.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,234,946,093.80 |
| Owner's Equity（Stockholder's Equity） |
4,269,430,863.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,740,917,547.82 |
